Australia's largest stock trading and investment forum Australia's #1 stock forum

NXS

Click for more information

2.86%

36.0¢ next science limited

Ann: Update on expected revenue for H1, page-17

First 17 Last

Share
Profile

Follow
Tarvold

18,472 Posts.

1201

11/06/21

18:11

Post #: 53802388
Share

Originally posted by tigertiger2: ↑

I agree with you. Xperience was approved in late April 2021. NXS can only proceed with those important trial runs (evidenced based-in recent investor briefing) that are needed to convince the surgeons only when xperience has been cleared by FDA. The trial runs have not even been completed.

Surely, Xperience can't be sold like pop corn without those trial runs to convince the surgeons.

Expand

NXS stated they had made sales almost from day 1.

NXS Price at posting: $1.76 Sentiment: None Disclosure: Not Held
1 Upvote

0 Great analysis

Reply

There are more pages in this discussion • 54 more messages in this thread...

First 17 Last

Add NXS (ASX) to my watchlist

(20min delay)
Last 36.0¢		Change 0.010(2.86%)		Mkt cap ! $103.5M

Open	High	Low	Value	Volume
36.0¢	36.0¢	35.5¢	$17.84K	49.80K

Buyers (Bids)

No.	Vol.	Price($)
1	1600	35.5¢

Sellers (Offers)

Price($)	Vol.	No.
36.0¢	32883	2

View Market Depth

No.	Vol.	Price($)
2	23850	0.350
2	26888	0.345
1	3000	0.340
1	2000	0.325
3	115500	0.320

Price($)	Vol.	No.
0.360	42883	2
0.365	2739	1
0.370	3075	1
0.380	320	1
0.385	2316	1

Last trade - 12.07pm 07/05/2024 (20 minute delay)


Last 35.0¢			Change 0.010 ( 0.00 %)
Open	High		Low	Volume
36.0¢	36.0¢		35.0¢	11563
Last updated 12.26pm 07/05/2024 ?

NXS (ASX) Chart

SPONSORED BY